Preventive Effect of Gamma-Oryzanol on Physiopathological Process Related to Nonalcoholic Fatty Liver Disease in Animals Submitted to High Sugar/Fat Diet
Main Author: | |
---|---|
Publication Date: | 2022 |
Other Authors: | , , , , , , , , |
Format: | Article |
Language: | eng |
Source: | Repositório Institucional da UNESP |
Download full: | http://dx.doi.org/10.3390/livers2030013 https://hdl.handle.net/11449/303412 |
Summary: | Nonalcoholic fatty liver disease (NAFLD) is the main cause of liver disease. The physiopathological processes involved in the disease are metabolic syndrome (MetS) components (central obesity, dyslipidemia, insulin resistance/type 2 diabetes, hypertension), genetic, and dietary factors, including unsaturated fats and sweetened beverages, which are able to lead to inflammation and oxidative stress, conditions associated with progression and severity of NAFLD. Gamma-oryzanol (γOz) is a nutraceutical obtained from rice brain oil with many benefits to health, from immunological to metabolic. The aim of this study is to test the preventive effect of γOz on the physiopathological process related to nonalcoholic fatty liver disease in animals submitted to high sugar/fat diet. Male Wistar rats (±187 g) were randomly divided into four experimental groups to receive: control diet (C, n = 6), control diet plus γOz (C + γOz, n = 6), high sugar/fat diet (HSF, n = 6), or high sugar/fat diet plus γOz (HSF + γOz, n = 6) during 30 weeks. HSF groups also received water plus sucrose (25%). γOz was added to diets to reach 0.5% of final concentration. The HSF group presented MetS, liver inflammation and oxidative stress, and micro and macrovesicular steatosis. HSF plus γOz was protected against these changes. It is possible to conclude that gamma-oryzanol was effective in modulating the physiopathological process related to nonalcoholic fatty liver disease in animals submitted to a high sugar/fat diet. |
id |
UNSP_07a3b01ff5aaf3ef34cb1ff9b79013cb |
---|---|
oai_identifier_str |
oai:repositorio.unesp.br:11449/303412 |
network_acronym_str |
UNSP |
network_name_str |
Repositório Institucional da UNESP |
repository_id_str |
2946 |
spelling |
Preventive Effect of Gamma-Oryzanol on Physiopathological Process Related to Nonalcoholic Fatty Liver Disease in Animals Submitted to High Sugar/Fat Dietbioactive compoundsgamma-oryzanolmetabolic syndromenonalcoholic fatty liver diseaseNonalcoholic fatty liver disease (NAFLD) is the main cause of liver disease. The physiopathological processes involved in the disease are metabolic syndrome (MetS) components (central obesity, dyslipidemia, insulin resistance/type 2 diabetes, hypertension), genetic, and dietary factors, including unsaturated fats and sweetened beverages, which are able to lead to inflammation and oxidative stress, conditions associated with progression and severity of NAFLD. Gamma-oryzanol (γOz) is a nutraceutical obtained from rice brain oil with many benefits to health, from immunological to metabolic. The aim of this study is to test the preventive effect of γOz on the physiopathological process related to nonalcoholic fatty liver disease in animals submitted to high sugar/fat diet. Male Wistar rats (±187 g) were randomly divided into four experimental groups to receive: control diet (C, n = 6), control diet plus γOz (C + γOz, n = 6), high sugar/fat diet (HSF, n = 6), or high sugar/fat diet plus γOz (HSF + γOz, n = 6) during 30 weeks. HSF groups also received water plus sucrose (25%). γOz was added to diets to reach 0.5% of final concentration. The HSF group presented MetS, liver inflammation and oxidative stress, and micro and macrovesicular steatosis. HSF plus γOz was protected against these changes. It is possible to conclude that gamma-oryzanol was effective in modulating the physiopathological process related to nonalcoholic fatty liver disease in animals submitted to a high sugar/fat diet.Medical School São Paulo State University (UNESP), SPInstitute of Biosciences São Paulo State University (UNESP), SPDepartment of Pathological Anatomy and Cytopathology Universidade do Oeste Paulista (UNOESTE), SPMedical School São Paulo State University (UNESP), SPInstitute of Biosciences São Paulo State University (UNESP), SPUniversidade Estadual Paulista (UNESP)Universidade do Oeste Paulista (UNOESTE)Francisqueti-Ferron, Fabiane Valentini [UNESP]Silva, Janaina Paixão das Chagas [UNESP]Garcia, Jéssica Leite [UNESP]Ferron, Artur Junio Togneri [UNESP]Kano, Hugo Tadashi [UNESP]Silva, Carol Cristina Vágula de Almeida [UNESP]Costa, Mariane Róvero [UNESP]Nai, Gisele AlborghettiMoreto, Fernando [UNESP]Corrêa, Camila Renata [UNESP]2025-04-29T19:29:31Z2022-09-01info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/article146-157http://dx.doi.org/10.3390/livers2030013Livers, v. 2, n. 3, p. 146-157, 2022.2673-4389https://hdl.handle.net/11449/30341210.3390/livers20300132-s2.0-85145849773Scopusreponame:Repositório Institucional da UNESPinstname:Universidade Estadual Paulista (UNESP)instacron:UNESPengLiversinfo:eu-repo/semantics/openAccess2025-04-30T14:08:57Zoai:repositorio.unesp.br:11449/303412Repositório InstitucionalPUBhttp://repositorio.unesp.br/oai/requestrepositoriounesp@unesp.bropendoar:29462025-04-30T14:08:57Repositório Institucional da UNESP - Universidade Estadual Paulista (UNESP)false |
dc.title.none.fl_str_mv |
Preventive Effect of Gamma-Oryzanol on Physiopathological Process Related to Nonalcoholic Fatty Liver Disease in Animals Submitted to High Sugar/Fat Diet |
title |
Preventive Effect of Gamma-Oryzanol on Physiopathological Process Related to Nonalcoholic Fatty Liver Disease in Animals Submitted to High Sugar/Fat Diet |
spellingShingle |
Preventive Effect of Gamma-Oryzanol on Physiopathological Process Related to Nonalcoholic Fatty Liver Disease in Animals Submitted to High Sugar/Fat Diet Francisqueti-Ferron, Fabiane Valentini [UNESP] bioactive compounds gamma-oryzanol metabolic syndrome nonalcoholic fatty liver disease |
title_short |
Preventive Effect of Gamma-Oryzanol on Physiopathological Process Related to Nonalcoholic Fatty Liver Disease in Animals Submitted to High Sugar/Fat Diet |
title_full |
Preventive Effect of Gamma-Oryzanol on Physiopathological Process Related to Nonalcoholic Fatty Liver Disease in Animals Submitted to High Sugar/Fat Diet |
title_fullStr |
Preventive Effect of Gamma-Oryzanol on Physiopathological Process Related to Nonalcoholic Fatty Liver Disease in Animals Submitted to High Sugar/Fat Diet |
title_full_unstemmed |
Preventive Effect of Gamma-Oryzanol on Physiopathological Process Related to Nonalcoholic Fatty Liver Disease in Animals Submitted to High Sugar/Fat Diet |
title_sort |
Preventive Effect of Gamma-Oryzanol on Physiopathological Process Related to Nonalcoholic Fatty Liver Disease in Animals Submitted to High Sugar/Fat Diet |
author |
Francisqueti-Ferron, Fabiane Valentini [UNESP] |
author_facet |
Francisqueti-Ferron, Fabiane Valentini [UNESP] Silva, Janaina Paixão das Chagas [UNESP] Garcia, Jéssica Leite [UNESP] Ferron, Artur Junio Togneri [UNESP] Kano, Hugo Tadashi [UNESP] Silva, Carol Cristina Vágula de Almeida [UNESP] Costa, Mariane Róvero [UNESP] Nai, Gisele Alborghetti Moreto, Fernando [UNESP] Corrêa, Camila Renata [UNESP] |
author_role |
author |
author2 |
Silva, Janaina Paixão das Chagas [UNESP] Garcia, Jéssica Leite [UNESP] Ferron, Artur Junio Togneri [UNESP] Kano, Hugo Tadashi [UNESP] Silva, Carol Cristina Vágula de Almeida [UNESP] Costa, Mariane Róvero [UNESP] Nai, Gisele Alborghetti Moreto, Fernando [UNESP] Corrêa, Camila Renata [UNESP] |
author2_role |
author author author author author author author author author |
dc.contributor.none.fl_str_mv |
Universidade Estadual Paulista (UNESP) Universidade do Oeste Paulista (UNOESTE) |
dc.contributor.author.fl_str_mv |
Francisqueti-Ferron, Fabiane Valentini [UNESP] Silva, Janaina Paixão das Chagas [UNESP] Garcia, Jéssica Leite [UNESP] Ferron, Artur Junio Togneri [UNESP] Kano, Hugo Tadashi [UNESP] Silva, Carol Cristina Vágula de Almeida [UNESP] Costa, Mariane Róvero [UNESP] Nai, Gisele Alborghetti Moreto, Fernando [UNESP] Corrêa, Camila Renata [UNESP] |
dc.subject.por.fl_str_mv |
bioactive compounds gamma-oryzanol metabolic syndrome nonalcoholic fatty liver disease |
topic |
bioactive compounds gamma-oryzanol metabolic syndrome nonalcoholic fatty liver disease |
description |
Nonalcoholic fatty liver disease (NAFLD) is the main cause of liver disease. The physiopathological processes involved in the disease are metabolic syndrome (MetS) components (central obesity, dyslipidemia, insulin resistance/type 2 diabetes, hypertension), genetic, and dietary factors, including unsaturated fats and sweetened beverages, which are able to lead to inflammation and oxidative stress, conditions associated with progression and severity of NAFLD. Gamma-oryzanol (γOz) is a nutraceutical obtained from rice brain oil with many benefits to health, from immunological to metabolic. The aim of this study is to test the preventive effect of γOz on the physiopathological process related to nonalcoholic fatty liver disease in animals submitted to high sugar/fat diet. Male Wistar rats (±187 g) were randomly divided into four experimental groups to receive: control diet (C, n = 6), control diet plus γOz (C + γOz, n = 6), high sugar/fat diet (HSF, n = 6), or high sugar/fat diet plus γOz (HSF + γOz, n = 6) during 30 weeks. HSF groups also received water plus sucrose (25%). γOz was added to diets to reach 0.5% of final concentration. The HSF group presented MetS, liver inflammation and oxidative stress, and micro and macrovesicular steatosis. HSF plus γOz was protected against these changes. It is possible to conclude that gamma-oryzanol was effective in modulating the physiopathological process related to nonalcoholic fatty liver disease in animals submitted to a high sugar/fat diet. |
publishDate |
2022 |
dc.date.none.fl_str_mv |
2022-09-01 2025-04-29T19:29:31Z |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
http://dx.doi.org/10.3390/livers2030013 Livers, v. 2, n. 3, p. 146-157, 2022. 2673-4389 https://hdl.handle.net/11449/303412 10.3390/livers2030013 2-s2.0-85145849773 |
url |
http://dx.doi.org/10.3390/livers2030013 https://hdl.handle.net/11449/303412 |
identifier_str_mv |
Livers, v. 2, n. 3, p. 146-157, 2022. 2673-4389 10.3390/livers2030013 2-s2.0-85145849773 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
Livers |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
146-157 |
dc.source.none.fl_str_mv |
Scopus reponame:Repositório Institucional da UNESP instname:Universidade Estadual Paulista (UNESP) instacron:UNESP |
instname_str |
Universidade Estadual Paulista (UNESP) |
instacron_str |
UNESP |
institution |
UNESP |
reponame_str |
Repositório Institucional da UNESP |
collection |
Repositório Institucional da UNESP |
repository.name.fl_str_mv |
Repositório Institucional da UNESP - Universidade Estadual Paulista (UNESP) |
repository.mail.fl_str_mv |
repositoriounesp@unesp.br |
_version_ |
1834482417988009984 |